Injectable silicone biomaterial for fecal incontinence caused by internal anal sphincter dysfunction is effective.
about
Perianal injectable bulking agents as treatment for faecal incontinence in adultsSurgery for faecal incontinence in adultsSurgery for faecal incontinence in adultsPerianal injectable bulking agents as treatment for faecal incontinence in adultsTreatment of fecal incontinence - review of observational studies (OS) and randomized controlled trials (RCT) related to injection of bulking agent into peri-anal tissueFaecal incontinence: Current knowledges and perspectivesSurgical management for fecal incontinenceSuccessful implantation of physiologically functional bioengineered mouse internal anal sphincter.Current and emerging treatment options for fecal incontinenceSphincter training or anal injections of dextranomer for treatment of anal incontinence: a randomized trial.An Open-Label, Noncomparative, Multicenter Study to Evaluate Efficacy and Safety of NASHA/Dx Gel as a Bulking Agent for the Treatment of Fecal IncontinenceIn vivo growth of a bioengineered internal anal sphincter: comparison of growth factors for optimization of growth and survival.Management of fecal incontinenceSuccessful implantation of bioengineered, intrinsically innervated, human internal anal sphincterLong-term efficacy of NASHA Dx injection therapy for treatment of fecal incontinence.Novel bulking agent for faecal incontinenceA prospective non-randomized two-centre study of patients with passive faecal incontinence after birth trauma and patients with soiling after anal surgery, treated by elastomer implants versus rectal irrigation.Towards safer treatments for benign anorectal disease: the pharmacological manipulation of the internal anal sphincter.The etiology, assessment, and treatment of fecal incontinence.Current diagnosis and treatment algorithms for anal incontinence.Sphincter contractility after muscle-derived stem cells autograft into the cryoinjured anal sphincters of ratsPilot study of two new injectable bulking agents for the treatment of faecal incontinence.Current management of fecal incontinence.Impact of fecal incontinence on quality of life.Multicentre observational study of the Gatekeeper for faecal incontinence.Fecal incontinence in women: causes and treatment.Current management of fecal incontinence: choosing amongst treatment options to optimize outcomes.Systematic review of perianal implants in the treatment of faecal incontinence.Anal bulking agents for faecal incontinence.Emerging surgical therapies for faecal incontinence.Current status: new technologies for the treatment of patients with fecal incontinence.[Treatment of sphincter insufficiency].Quality of life and functional results of submucosal injection therapy using dextranomer hyaluronic acid for fecal incontinence.The use of Permacol® injections for the treatment of faecal incontinence.Efficacy and quality of life 2 years after treatment for faecal incontinence with injectable bulking agents.Long-term evaluation of bulking agents for the treatment of fecal incontinence: clinical outcomes and ultrasound evidence.Treatments of faecal incontinence: recommendations from the French national society of coloproctology.The greatest taboo: urinary incontinence as a source of shame and embarrassment.Accuracy of anorectal manometry in patients with fecal incontinence.Comparison of bulking agents in the treatment of fecal incontinence: a prospective randomized clinical trial.
P2860
Q24200587-2BB4B7AA-EA5E-4AA6-9A09-7CEA7FC4E69FQ24201396-854C7DC1-DC05-4406-98D3-73F6DDA8AE13Q24235335-A38378D6-0E97-4A0C-B15C-097680AE0BC0Q24235376-7B27EEB4-F3CC-4329-BBDE-0F6D15A9312CQ24622508-6BCC71AF-7A4B-4B28-9038-5F946142C17BQ26766667-BABCC6F8-2BE7-46A7-8D3D-18BD4A39BABDQ27013913-78164E18-B5DA-4A21-B7C6-6E3A0498D6CEQ34085282-F1743B58-F618-4B73-852C-9E0333ACE02AQ34196874-C1C9AE37-AA10-4B17-8F61-3632B468927DQ34321470-941F1389-E17C-4A6A-B9C3-801104C9C46EQ34475535-EE3EC2AD-EDE7-4E9E-B755-8293D54638D2Q34500755-99810D86-5E67-44F2-AF48-B14EF7651221Q35014637-593616D6-119C-45DC-8070-5256ACC45390Q35085844-D6876EE4-7C28-4DDE-B59F-92C69CC216F6Q35211754-91853B44-4DA0-4395-BDD0-20E07077ABBFQ35590199-5494E405-16C2-4B68-99F7-1A1E48E1E781Q36199137-F9685905-76DB-4C5B-AABD-C6AD385E0735Q36238196-367114BB-8E1B-47D3-A8B2-72B19DFF80CBQ36342337-2EC9096D-5039-4177-A523-4429D3D9AF7FQ36566868-70BF8EE7-3716-4FA9-8843-6DE8E504AC90Q36839060-16E71654-75E8-4E52-A385-A0991B0025B9Q36892920-1F409AE6-2298-4A7D-9C6F-26212DA6E085Q37197568-393BA327-7B81-4BB9-BCE3-04BB80E0B881Q37262063-40AB0A7C-97A4-487A-9776-B1C23D57F897Q37337411-D8274DA7-AD1E-47DE-93AC-2970B37F9070Q37346137-90A62ED4-49C1-4686-9FE7-9431020FBFAAQ37439883-1B922FF3-95BF-4497-9050-E9BFF66211CFQ37941477-3492E9C3-60C6-4D2A-81E4-F9C730ABE31AQ38058526-C1A87B20-F4B1-45EF-ACEE-8324131F03BEQ38166181-243594D1-6B4E-42E4-8D2A-17947C7F03FBQ38194462-C9728797-6F67-477F-8374-A7CDDA4E6C98Q39234914-05CE4850-E549-4786-8C84-C2EF3E5C10DAQ43325587-54ACCB1C-E3FA-4770-B150-95254BF7E0CDQ43348918-886D23D4-A62E-4DFD-AB1A-C2ECF724BC5FQ43352631-2654DC8B-5454-415D-8F17-741E4D9833C7Q46713656-4170254B-6CC0-49E5-9CB9-912392E4F0A6Q46861078-89EF5846-E846-40FC-B400-136F8FAC815BQ47264280-5252C896-078B-4609-B554-EBE601925F98Q47340884-82F69FE7-AEE1-451D-BD2F-CF2F9B4C1FC5Q48023709-2FB20FBC-05BC-473F-B9A5-42EBA7B2BE71
P2860
Injectable silicone biomaterial for fecal incontinence caused by internal anal sphincter dysfunction is effective.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh-hant
name
Injectable silicone biomateria ...... cter dysfunction is effective.
@en
Injectable silicone biomateria ...... cter dysfunction is effective.
@nl
type
label
Injectable silicone biomateria ...... cter dysfunction is effective.
@en
Injectable silicone biomateria ...... cter dysfunction is effective.
@nl
prefLabel
Injectable silicone biomateria ...... cter dysfunction is effective.
@en
Injectable silicone biomateria ...... cter dysfunction is effective.
@nl
P2093
P1476
Injectable silicone biomateria ...... cter dysfunction is effective.
@en
P2093
P2888
P304
P356
10.1007/S10350-004-0760-3
P577
2004-12-01T00:00:00Z